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Neuron populations of the lateral hypothalamus which synthesize the orexin
(OX)/hypocretin or melanin-concentrating hormone (MCH) peptides play crucial,
reciprocal roles in regulating wake stability and sleep. The disease human African
trypanosomiasis (HAT), also called sleeping sickness, caused by extracellular
Trypanosoma brucei (T. b.) parasites, leads to characteristic sleep-wake cycle disruption
and narcoleptic-like alterations of the sleep structure. Previous studies have revealed
damage of OX and MCH neurons during systemic infection of laboratory rodents
with the non-human pathogenic T. b. brucei subspecies. No information is available,
however, on these peptidergic neurons after systemic infection with T. b. gambiense,
the etiological agent of 97% of HAT cases. The present study was aimed at the
investigation of immunohistochemically characterized OX and MCH neurons after T. b.
gambiense or T. b. brucei infection of a susceptible rodent, the multimammate mouse,
Mastomys natalensis. Cell counts and evaluation of OX fiber density were performed at
4 and 8 weeks post-infection, when parasites had entered the brain parenchyma from
the periphery. A significant decrease of OX neurons (about 44% reduction) and MCH
neurons (about 54% reduction) was found in the lateral hypothalamus and perifornical
area at 8 weeks in T. b. gambiense-infected M. natalensis. A moderate decrease (21%
and 24% reduction, respectively), which did not reach statistical significance, was found
after T. b. brucei infection. In two key targets of diencephalic orexinergic innervation,
the peri-suprachiasmatic nucleus (SCN) region and the thalamic paraventricular nucleus
(PVT), densitometric analyses showed a significant progressive decrease in the density
of orexinergic fibers in both infection paradigms, and especially during T. b. gambiense
infection. Altogether the findings provide novel information showing that OX and MCH
neurons are highly vulnerable to chronic neuroinflammatory signaling caused by the
infection of human-pathogenic African trypanosomes.
Keywords: human African trypanosomiasis, orexin, hypocretin, melanin-concentrating hormone,
neuroinflammation, sleep, wake
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INTRODUCTION
Many infections disturb sleep, and somnolence is part of the
so-called sickness behavior in response to infections (Poon et al.,
2015). The alterations of sleep in humanAfrican trypanosomiasis
(HAT) are, however, so characteristic and severe that they
gave to the disease the alternative name of sleeping sickness
(Buguet et al., 2014; Büscher et al., 2017). HAT is caused by
the extracellular protozoan parasites Trypanosoma brucei (T. b.),
inoculated through bites of the hematophagous tsetse flies (genus
Glossina). The disease is still endemic, with a focal distribution
mostly in remote rural areas, in the vast sub-Saharan region
of the vector’s habitat. After an epidemic in the 1990s, this
neglected tropical disease has attracted attention in the public
health agenda. Due to sustained control activities, the reported
cases have declined in recent years (dropping to less than
3000 in 2015) and the disease is currently targeted for elimination
(WHO, 2017). There are, however, concerns on the fight against
HAT and worries about disease re-emergence, especially due to
inaccurate case reporting and to silent carriers (Welburn et al.,
2016; Büscher et al., 2017).
The vast majority of HAT cases (97%; WHO, 2017) are
due to the infection of T. b. gambiense, for which humans
provide the reservoir, causing a chronic progressive form of
the disease with a course from 1 to 3 years. T. b. gambiense
HAT is endemic in western and central Africa, and especially
in the Democratic Republic of Congo (DRC) where over 70%
of cases in the last 10 years have been reported (WHO,
2017). A more acute form of HAT, lasting 6–8 months, is
endemic in eastern and southern Africa and is caused by
T. b. rhodesiense, representing a zoonosis with wildlife and
livestock reservoirs and therefore difficult to control. Most
experimental studies on nervous system infection caused by
African trypanosomes have been performed using a third parasite
subspecies, T. b. brucei, which is infectious to animals but not to
humans.
During the progression of T. b. infection, the parasites,
which initially invade peripheral organs through the blood and
lymph, enter the central nervous system parenchyma. HAT is
considered fatal if untreated (WHO, 2017) and the therapy of
the meningoencephalitic stage is very toxic. Ongoing clinical
trials based on oral therapy with fexinidazole are opening new
perspectives for the cure of HAT (Mesu et al., 2018).
The disease causes severe chronic neuroinflammation, with
high levels of inflammatory mediators (Kennedy, 2013; Büscher
et al., 2017). Early autoptic studies of HAT victims have
shown glial activation with myelin pallor but no features of
neurodegeneration (Lejon et al., 2013). The clinical picture,
initially nonspecific, leads to a constellation of neurological
and psychiatric alterations during disease progression (Kennedy,
2013; Lejon et al., 2013; Buguet et al., 2014; Büscher et al.,
2017). Since historical descriptions, striking clinical features
of HAT in endemic regions are represented by diurnal
somnolence and nocturnal insomnia, as well as episodes of
irresistible sleep during wakefulness (sleep attacks; Lhermitte,
1910; Blum et al., 2006; Buguet et al., 2014). Polysomnographic
recordings of the sleep-wake cycle in HAT patients have
shown that the disease does not cause hypersomnia but rather
a circadian disruption of sleep-wake alternation, as well as
alterations of the sleep structure (Buguet et al., 2001, 2005,
2014).
Sleep-wake cycle changes during African trypanosomiasis
implicate the master circadian pacemaker, the hypothalamic
suprachiasmatic nucleus (SCN), which drives endogenous
biological rhythms in the mammalian brain (van Esseveldt
et al., 2000; Golombek and Rosenstein, 2010; Moore, 2013).
Findings on neuronal cell loss in the SCN of an animal model
of T. b. gambiense infection provided by the multimammate
mouse, Mastomys natalensis (Mehlitz, 1975; Büscher et al.,
2005) are presented in a companion article (Tesoriero et al.,
2018). On the other hand, alterations of sleep architecture
in African trypanosomiasis implicate damage to structures
of the distributed neural network which regulates sleep and
wakefulness (Saper et al., 2010; Scammell et al., 2017). In
particular, the observation of sudden sleep episodes during
wakefulness, as well as sleep fragmentation and disruption
of the normal sleep sequence which also occur in T. b.
brucei-infected rats (Darsaud et al., 2003; Seke Etet et al.,
2012; Laperchia et al., 2016, 2017) recall the chronic sleep
disorder narcolepsy (Sateia, 2014; Scammell, 2015), whose
pathogenesis is due to impaired orexinergic signaling (Liblau
et al., 2015). Such alterations point, therefore, to dysfunction
of neurons which contain the orexin (OX)/hypocretin peptides,
located in the posterior lateral hypothalamus. These neurons
play a key role in wakefulness stability and sleep-wake
transitions (de Lecea and Huerta, 2014), besides their implication
in energy homeostasis and other physiological functions
underlying motivated behaviors (Sakurai, 2014; Li et al.,
2016).
Orexinergic neurons are intermingled with those expressing
another peptide, melanin-concentrating hormone (MCH), which
are sleep-promoting and also regulate food intake and other
functions implicated in the motivational aspects of behavior
(Torterolo et al., 2015; Ferreira et al., 2017). Structural and
functional alterations of these two major hypothalamic neuronal
populations has been previously reported in T. b. brucei-
infected laboratory rats and mice (Palomba et al., 2015), but
no information on these cell groups during T. b. gambiense
infection is available. To fill this gap of knowledge, the present
study was aimed at the histopathological investigation of OX and
MCH cell bodies and OX fibers in the animal model of T. b.
gambiense infection provided by M. natalensis. This rodent is
sensitive to T. b. gambiense infection (Mehlitz, 1978), at variance
with laboratory rodents which are not susceptible tomost isolates
of this human-pathogenic parasite subspecies (Giroud et al.,
2009).
OX neurons give origin to extensive projections (Peyron
et al., 1998). In particular, in laboratory rodents orexinergic
fibers innervate the area surrounding the SCN (Peyron et al.,
1998; Marston et al., 2008), and show a discrete distribution
in the thalamus along the midline with dense innervation
of the thalamic paraventricular nucleus (PVT; Peyron et al.,
1998; McGranaghan and Piggins, 2001; Mintz et al., 2001;
Kirouac et al., 2005) documented also in African rodents
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(Bhagwandin et al., 2011a). The density of OX innervation was
here evaluated in these two diencephalic targets of orexinergic
projections, the peri-SCN region and PVT, given their high
functional relevance for interactions between circadian and
vigilance state regulation (Colavito et al., 2015).
MATERIALS AND METHODS
Animals and Infection
Experimental procedures were performed under approval of the
ethical committee of the Ministry of Health of DRC, adhering
to the European Communities Council (86/609/EEC) directives
and the ARRIVE (‘‘Animal Research Reporting of in vivo
Experiments’’) guidelines. All efforts were made to minimize
animal number and suffering. The present investigation was
based on the same brains of the animals used for the study of the
SCN presented in a companion article (Tesoriero et al., 2018).
In brief, adult M. natalensis of both sexes (a total number
of 45 animals, 30 destined to the two infection paradigms and
15 controls) were obtained from the breeding colony at the
Institut National de Recherche Biomedicale (INRB, Kinshasa,
DRC).
The rodent M. natalensis is very widespread in sub-Saharan
Africa, and holds a taxonomic position between the mouse
(house mouse) and the rat (ship, roof rat; Coetzee, 1975).
The definition of multimammate derives from a uniquely large
number of mammae in the female (Isaäcson, 1975).M. natalensis
(also called Praomys natalensis) is nocturnal, with the peak of
activity in the first 3 h of the period of darkness (Coetzee,
1975). The animal is omnivorous, uses preferentially burrows
of other rodents for nesting and adapts easily to different
environments (Isaäcson, 1975), representing the major rodent
pest in sub-Saharan Africa (e.g., Mulungu et al., 2013).
The animals were maintained under a 12 h:12 h light/dark
cycle, with free access to food and water. One group of animals
was infected with T. b. gambiense (MHOM/INRB/2006/11A,
originally isolated from a patient in DRC in 2006), and another
group with T. b. brucei (AnTat 1.1E). The parasites derived
from the cryostabilates collected at INRB, and each experimental
group of infected M. natalensis included matched uninfected
controls. The infection was done with intraperitoneal injection
of 0.25 ml per animal of a solution (0.1 M phosphate buffer,
pH 7.4, supplemented with glucose) containing 106.9–107.2
trypanosomes/ml. Parasitaemia was verified weekly from the tip
of the tail vein. At 4 and 8 weeks post-infection, the animals
(n = 3 or 4 infected animals per time point and control
animals per experimental group) were sacrificed during daytime,
under anesthesia, by transcardial perfusion with ice-cold 0.9%
saline followed by formaldehyde solution (obtained dissolving
paraformaldehyde in 0.1 M phosphate buffer, pH 7.2, at
a 4% concentration). Previous monitoring at INRB of the
natural course of the infections in M. natalensis indicated
that at 8 weeks T. b. brucei infection is in a very advanced
phase (and this was therefore selected as end-point of the
study), whereas T. b. gambiense infection can last several
weeks.
After perfusion, the brains were removed from the skull,
posfixed for a few hours, and then stored until processing at 4◦C
in 0.01 M phosphate buffered-saline, pH 7.4 (PBS), containing
0.1% sodium azide.
Tissue Processing and
Immunohistochemistry
Following cryoprotection in 30% sucrose in PBS, the brains were
cut on the coronal plane with a freezing microtome into 30 µm-
thick sections, which were collected in six series. One series
of sections was stained with cresyl violet for cytoarchitectonic
control.
Two series of sections through the hypothalamus were
processed free-floating for OX immunohistochemistry. The
peptides OX-A andOX-B, also called hypocretin-1 and 2, cleaved
from the common precursor prepro-OX, are largely co-localized
in the same neurons (Nixon and Smale, 2007), and OX-A
is more stable than OX-B. OX-A immunophenotyping was
therefore used to investigate orexinergic neurons in the present
study. The sections were first soaked in 1% H2O2 in PBS for
20 min to inactivate endogenous peroxidase activity, and then
pre-incubated in a solution of 5% bovine serum albumin (BSA)
and 0.3% Triton X-100 in PBS for 1 h at room temperature.
Subsequently, the sections were incubated overnight at room
temperature in polyclonal goat anti-OX-A antibody (1:500; Santa
Cruz, CA, USA) diluted in PBS containing 1% BSA, 0.2%
Triton X-100. Following thorough washes, the sections were
incubated for 2 h in biotinylated horse anti-goat IgGs (1:200,
Vector, Burlingame, CA, USA), and finally reacted with avidin-
peroxidase complex (1:100, Vector, Burlingame, CA, USA) for
1 h and with 3,3′-diaminobenzidine (DAB) as chromogen.
The second series was processed further for MCH
immunohistochemistry based on a two-color protocol (Peng
et al., 1995). These sections were incubated overnight at
room temperature in polyclonal rabbit anti-MCH antibody
(1:1000; Phoenix Pharmaceuticals, Burlingame, CA, USA).
After repeated washing, the sections were incubated for 2 h
in biotinylated goat anti-rabbit IgGs (1:200, Vector) and then
reacted with avidin-peroxidase complex (1:100; Vector) for
1 h. In the last step of the procedure, the sections were reacted
in a freshly prepared and filtered solution containing 0.05%
α-naphthol, 0.1% ammonium carbonate, and 0.003% H2O2 in
PBS. The dark blue reaction product was turned into pink by
an additional incubation in 0.1% phosphate-buffered pyronin
B. This procedure results in the simultaneous visualization in
bright-field microscopy of brown DAB reaction products of the
first incubation and pink reaction products of the second run
(Peng et al., 1995).
After immunohistochemical processing, all sections were
thoroughly washed in PBS, mounted on gelatin-coated slides,
air-dried, dehydrated, cleared and coverslipped with Entellan.
Specific immunostaining was absent in control sections in which
the primary antibodies were omitted.
The presence of parasites in the brain parenchyma was
investigated in additional sections through the telencephalon
and diencephalon, which were processed for double
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FIGURE 1 | Confocal microscopy images showing parasites (in red) in the brain parenchyma at 8 weeks (W) after Trypanosoma brucei brucei (Tbb) or Trypanosoma
brucei gambiense (Tbg) systemic infection. Blood vessel walls are visualized by anti-glucose transporter-1 immunolabeling (in green). Scale bar: 40 µm.
immunofluorescence. These sections were incubated with a
mixture of primary antibodies: rabbit polyclonal antibodies
which recognize the anti-variant surface glycoprotein of the
AnTat 1:1E stabilate (1:200; kindly provided by Philippe
Büscher, Institute of Tropical Medicine, Antwerp, Belgium)
to visualize the parasites, and goat polyclonal anti-glucose
transporter-1 antibodies (1:100, Santa Cruz Biotechnology)
to visualize blood vessel endothelia (Pardridge et al., 1990).
The sections were rinsed in PBS and incubated in a solution
of species-specific secondary antibodies conjugated with
Cy2 or Cy3 (1:100; Jackson ImmunoResearch, Suffolk, UK),
rinsed in PBS, mounted on slides using a fluorescence-
compatible medium (Dako, Hamburg, Germany) and stored
at 4◦C.
Data Analysis and Statistics
The sections processed for immunofluorescence for parasite
detection were observed with a confocal laser scanning
microscope (Zeiss LSM 510 Carl Zeiss, Jena, Germany), equipped
with an argon laser emitting at 488 nm (Cy2) and a helium/neon
laser emitting at 543 nm (Cy3). The other sections were
investigated in bright-field microscopy and quantitative analyses
FIGURE 2 | Low power view of orexin (OX)-A-immunoreactive neurons in the perifornical area and lateral hypothalamus of Mastomys natalensis at 4 weeks (W) and
8 W after infection with Trypanosoma brucei brucei (Tbb) or Trypanosoma brucei gambiense (Tbg) and in uninfected animals. Note the rarefaction of immunostained
cell bodies and the reduction of neuropil immunolabeling in the infected animals. Abbreviations: f, fornix; opt, optic tract. Scale bar: 250 µm.
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were pursued in three animals per group, blindly of the animal’s
experimental group assignment.
The series of sections processed for OX-A single
immunohistochemistry was used for OX cell counts, and
that processed for double immunohistochemistry for MCH cell
counts. The number of OX and MCH cells was determined
stereologically using the optical fractionator method throughout
the rostrocaudal extent of the perifornical area and lateral
hypothalamus. Cells were visualized using an Olympus
BX51 microscope (20× objective) with a motorized stage
connected to a digital camera (JVC CCD KY-F58) and equipped
with the image analysis digital system Stereo-Investigator
software (MicroBrightfield Corp.). For a systematic random
sampling, a grid centered on the fornix and adjacent medially
to the wall of the third ventricle was used. The grid was divided
into nine counting frames, allowing also partial cell counts in the
medial, middle and lateral portions of the lateral hypothalamus.
Only cells within the frame or touching one of the frame borders
were counted.
For densitometric evaluation, three regularly spaced sections
were sampled through the middle portion of the SCN and
PVT, respectively, from each animal. In each section, under
calibrated constant light parameters, four images from the PVT
and two images from the peri-SCN region (within an area of
300 µm in length lateral to the SCN) were randomly sampled
on each side using a 40× objective (NA 0.75; yielding a frame of
0.0256mm2). OX immunoreactivity signal was thenmeasured by
defining the zero value of optical density (OD) as background,
measured in a portion of the section tissue devoid of specific
immunostaining. For each region of interest (ROI), the values
from each section were averaged. A grand mean for each ROI
was then computed from the mean value derived from each
section.
Data are reported as mean ± standard error of the
mean (SEM). Kruskal-Wallis analysis of variance followed by
the Dunn’s test for pairwise comparison was used for the
statistical evaluation of cell counts. One-way analysis of variance
followed by the LSD post hoc test was used for OD values of
immunoreactivity of OX fibers in the peri-SCN region and PVT.
Significance threshold was set at P < 0.05.
RESULTS
Trypanosomes in the Brain Parenchyma
Double immunofluorescence showed in M. natalensis the
occurrence of T. b. gambiense and T. b. brucei outside blood
vessels within the brain parenchyma, in variable amounts, at both
4 weeks and 8 weeks (Figure 1) after infection, as also presented
in the companion article (Tesoriero et al., 2018). This indicated
that in both paradigms the infection was in the encephalitic stage
at the sampled time points.
OX and MCH Cell Bodies
In M. natalensis, OX-immunolabeled neurons showed a
distribution similar to that described in laboratory rodents
(Peyron et al., 1998; Mintz et al., 2001) and in a variety of African
rodents (Bhagwandin et al., 2011a,b; Sweigers et al., 2017). The
largest population was concentrated in the perifornical area,
from which it extended to the lateral hypothalamus (Figure 2).
MCH neurons also showed in the hypothalamus the distribution
described in rodents, very similar, in particular, to that reported
in the rat (Bittencourt, 2011). Thus, MCH neurons were
distributed rostrally in the incerto-hypothalamic area, between
the fornix and the internal capsule at the level of the tuberal
lateral hypothalamus. Proceeding posteriorly, MCH neurons
were densely aggregated around the fornix, and with sparser
distribution medially to the internal capsule, as well as dorsally
in the zona incerta, and with a medial, periventricular location.
MCH neurons were intermingled with OX neurons in the
perifornical area and lateral hypothalamus, and also surrounded
OX neurons dorsally and ventrally. OX and MCH somata were
morphologically similar, with a multipolar or fusiform shape
(Figures 3A,B, 4), giving origin to varicose fibers.
A decrease in the density of OX cell bodies and neuropil
immunostaining after African trypanosome infection at both the
sampled time points was evident even at low power observation
along the rostrocaudal and mediolateral axes (Figure 2). At
FIGURE 3 | (A,B) Images of orexin-A-immunoreactive neurons in uninfected
Mastomys natalensis (B represents at higher power the area boxed in A), and
at 4 weeks (W) and 8 W after infection with Trypanosoma brucei brucei (Tbb)
or Trypanosoma brucei gambiense (Tbg) (C–F). Abbreviations: f, fornix; opt,
optic tract. Scale bars: 250 µm in (A), 150 µm in (E) (applies also to B–D,F).
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FIGURE 4 | Images of OX-A-immunoreactive neurons (brown) and melanin-concentrating hormone (MCH)-immunoreactive neurons (purple) through the middle third
(upper row) and posterior third (lower row) of the lateral hypothalamus of uninfected Mastomys natalensis and at 8 weeks (W) after infection with Trypanosoma brucei
brucei (Tbb) or Trypanosoma brucei gambiense (Tbg). Note the marked shrinkage of many MCH-immunostained neurons. Scale bar: 150 µm.
FIGURE 5 | The bar graphs illustrate the stereological counts of neurons containing OX-A (A,B) or MCH (C,D) in control (ctrl) Mastomys natalensis and at 4 weeks
(W) and 8 W after infection with Trypanosoma brucei (T. b.) brucei (A,C) or T. b. gambiense (B,D). ∗P < 0.05; ∗∗P < 0.001.
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higher power, the intensity of the soma immunostaining
appeared relatively preserved in the infected animals, but with
less extensive dendritic filling than in matched controls, and
some cell bodies appeared shrunken (Figures 3C–F). Also
the density of MCH neurons appeared decreased in both
paradigms of infection, with shrinkage of many cell bodies
(Figure 4).
Cell counts documented a progressive decrease of both
peptidergic cell populations, which was more marked after
T. b. gambiense infection than in the T. b. brucei-infected
animals (Figure 5). In particular, after T. b. brucei infection the
reduction of OX-immunostained cells with respect to controls
was 11.12 ± 6.8% at 4 weeks and 21.34 ± 9.8% at 8 weeks,
and that of the MCH-immunostained cells, evaluated in the
lateral hypothalamus and perifornical area, was 17.53 ± 10.6%
at 4 weeks and 24.45 ± 2.2% at 8 weeks. These decreases did
not reach, however, statistical significance. After T. b. gambiense
FIGURE 6 | Top: images of the ventral part of the anterior hypothalamus
showing OX-A immunoreactive fibers in the region lateral to the
suprachiasmatic nucleus (SCN, delimited by a dotted line), in Mastomys
natalensis at 4 weeks (W) and 8 W after infection with Trypanosoma brucei
brucei (Tbb) or Trypanosoma brucei gambiense (Tbg). Note that the decrease
in the immunoreactive fiber density, especially at 8 weeks after T. b.
gambiense infection. Scale bar: 250 µm. Bottom: bar graphs of the
quantitative densitometric evaluation of OX-A immunosignal in the peri-SCN
region in control (ctrl) and infected animals. ∗P < 0.05; ∗∗∗P < 0.001.
Abbreviations: OD, optical density; OX, optic chiasm.
infection, 21.58 ± 7.6% reduction of OX-immunostained cells
was documented at 4 weeks, and 43.78 ± 7.4% reduction at
8 weeks, when the cell number decrease vs. matched controls was
significant. Evenmoremarked was the decrease ofMCHneurons
(48.15 ± 4% reduction at 4 weeks and 54.15 ± 6.3% at 8 weeks),
which was significant at both survival times.
Partial cell counts showed that loss of immunostained cell
bodies occurred throughout the extent of their distribution in the
lateral hypothalamus and perifornical area.
OX Fibers
In uninfected M. natalensis, orexinergic fibers were found to
be densely aggregated laterally to the SCN, as well as along
the thalamic midline, innervating PVT throughout its extent.
A significant density decrease was found in the orexinergic
innervation of the peri-SCN region at 4 and 8 weeks after
T. b. brucei infection (Figure 6). In PVT, T. b. brucei
infection resulted in a reduction of orexinergic fiber density at
4 weeks, which was further reduced, and significant, at 8 weeks
(Figure 7). In the peri-SCN region of T. b. gambiense-infected
FIGURE 7 | Top: images of the paraventricular thalamic nucleus (PVT) of
Mastomys natalensis showing OX-A-immunoreactive fibers at 4 weeks (W)
and 8 W after infection with Trypanosoma brucei brucei (Tbb) or Trypanosoma
brucei gambiense (Tbg). Note the marked decrease of PVT orexinergic
innervation, especially after T. b. gambiense infection (see also Figure 6).
Scale bar: 250 µm. Bottom: bar graphs of the quantitative densitometric
evaluation (OD, optical density) of OX-A immunosignal in PVT of control (ctrl)
and infected animals. ∗P < 0.05; ∗∗∗P < 0.001.
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FIGURE 8 | Images of orexin-A-immunoreactive preterminal and fibers in the paraventricular thalamic nucleus of uninfected Mastomys natalensis (A,C) and at 8
weeks after infection with Trypanosoma brucei gambiense (B,D). (C,D) represent at higher magnification fields of (A,B), respectively, as indicated by the asterisks for
spatial landmark. Note in (C) the abundance of varicose fibers in the control animals and note in (D) their marked decrease and fragmentation in the infected animal.
Abbreviation: D3V, dorsal third ventricle. Abbreviation: D3V, dorsal third ventricle. Scale bars: 200 µm in (A,B), 50 µm in (C,D).
animals the decrease in the density of orexinergic fibers was
very marked and highly significant at 8 weeks (Figure 6).
Extreme reduction of orexinergic innervation was found in
PVT at both 4 and 8 weeks after T. b. gambiense infection
(Figures 7, 8).
DISCUSSION
The present findings show that T. b. gambiense infection leads
to progressive quantitative decrease of OX and MCH neurons,
and that this is more marked than that caused by T. b.
brucei infection in the same host species, susceptible to both
parasite subspecies. At the endpoint of the study (8 weeks post-
infection), the reduction of OX neurons in M. natalensis was
about 44% and that of MCH neurons accounted for the loss
of about 54% of these neurons in the lateral hypothalamus
and perifornical area. Of note, considerable damage of MCH
neurons was documented in M. natalensis also at an earlier
phase of the encephalitis (about 48% reduction of MCH neurons
and about 21% reduction of OX neurons at 4 weeks post-
infection).
Immunophenotyping could not here reveal whether the
decrease was due to cell death phenomena or downregulation of
peptide expression below the threshold of immunohistochemical
visualization. However, in the infected animals immunostaining
showed cell damage suggestive of an ongoing degenerative
process, previously documented also in T. b. brucei-infected
laboratory rodents in the absence of overall cell loss in the
hypothalamus (Palomba et al., 2015).
The present analyses in infected M. natalensis also
demonstrated significantly impoverished orexinergic
innervation, which was especially marked after T. b. gambiense
infection. This was here shown in the peri-SCN region, which
is in turn involved in the circadian control of OX neuron
activation (Marston et al., 2008; Belle et al., 2014; Belle and
Piggins, 2017) that could be thus impaired during the infection.
Decreased orexinergic input was also here documented in
PVT, the thalamic midline structure in which OX release
exerts powerful functional effects, and which plays a key
role in funnelling state-dependent behavior information
into the limbic system and prefrontal cortex (Colavito et al.,
2015).
Loss of OX neurons (90% or greater) is the neuropathological
hallmark of narcolepsy, and in particular of narcolepsy with
cataplexy (sudden loss of postural muscle tone, triggered
especially by emotion; Peyron et al., 2000; Thannickal et al.,
2000). OX neurons degenerate also in narcolepsy without
cataplexy, as reported in a post-mortem brain examination which
showed loss of 33% of OX neurons (Thannickal et al., 2009).
Besides narcoleptic-like changes of sleep architecture in HAT,
the clinical phenotype of the sleep-wake cycle is, however, very
different in this disease and in narcolepsy, since narcolepsy does
not include circadian rhythm disturbances (Dantz et al., 1994).
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The investigation of OX levels in the cerebrospinal fluid
(CSF) of T. b. gambiense HAT patients (Dauvilliers et al.,
2008) and T. b. brucei-infected rats (Palomba et al., 2015)
have shown a decrease, which, however, was not significant
and exhibited high interindividual variability. The concentration
of OX in the CSF of narcoleptics with typical cataplexy is
very low, whereas it is normal in most cases of narcolepsy
without cataplexy, as well as in other neurodegenerative or
neurotraumatic conditions which lead to partial loss of OX
neurons (Bourgin et al., 2008). On the other hand, experimental
evidence based on lesions of OX neurons in the rat has
shown that a very large cell loss is needed to impair OX
level in the CSF, which points to a considerable compensatory
capacity of surviving OX neurons (Gerashchenko et al.,
2003).
Importantly, polysomnographic recording of a limited
cohort of T. b. gambiense HAT patients has shown that the
narcoleptic-like sleep structure alterations can slowly recover
after trypanocydal therapy, especially when patients are not
severely ill (Buguet et al., 1999). This suggests that functional
compensation can be effective when the disease is promptly
cured.
The present finding of MCH neuron damage shows that
T. b. gambiense infection does not affect OX neurons selectively.
This also occurs in other conditions. For example, sleep disorders
represent prominent non-motor symptoms in Parkinson’s
disease, and loss of both OX and MCH neurons, increasing with
disease severity, has been reported in post-mortem studies of
the hypothalamus of victims of this disease (Thannickal et al.,
2007). It is relevant to recall, in this respect, that MCH neurons
are instead spared in the brain of narcoleptic patients with or
without cataplexy (Peyron et al., 2000; Thannickal et al., 2000,
2009). Altogether the findings indicate that T. b. gambiense
infection disrupts the interplay between OX and MCH neurons,
supporting data obtained in laboratory rodents after T. b. brucei
infection (Palomba et al., 2015). These peptidergic neurons not
only play reciprocal roles in the regulation of vigilance states
(Konadhode et al., 2015), but are also interconnected. Notably,
MCH neurons exert an inhibitory influence on OX neurons,
tuning the overall output of these two systems (Rao et al.,
2008).
Interestingly, the reduction of OX and MCH neurons here
documented in T. b. gambiense infection is much more marked
than that provoked by local (intra-hypothalamic) infusion of
the endotoxin lipopolysaccharide for 1 month (Gerashchenko
and Shiromani, 2004). Experimental studies based on T. b.
brucei infection have indicated an escalating inflammatory
response during disease progression (Kristensson et al., 2010)
in which the posterior hypothalamus is especially involved
(Laperchia et al., 2016). Parasites reside in the median eminence,
as in other circumventricular organs, since the first stage of
hemolymphatic infection (Kristensson et al., 2010). The posterior
hypothalamus is an early site of parasite traversal of blood-
brain barrier through gradients of permeability from themedian-
eminence-arcuate nucleus complex (Laperchia et al., 2016). This
hypothalamic complex is known to represent a first order
station for peripheral signals, transmitting information to the
second order network provided by OX and MCH neurons
(Guyon et al., 2009; Rostène et al., 2011). It may therefore
not be surprising that these peptidergic cell populations are
targeted by chronic inflammatory signaling during African
trypanosomiasis.
Several data sets point to vulnerability of OX (Grossberg et al.,
2011) and MCH (Sergeyev et al., 2001) neurons to inflammatory
molecules. OX neurons are especially sensitive to nitric oxide
toxicity (Obukuro et al., 2013). MCH neurons are very sensitive
to signaling mediated by the CCL2 chemokine (Le Thuc et al.,
2016). The expression of this chemokine in the brain during
African trypanosomiasis remains to be explored, but CCL2 is part
of the panel of inflammatory mediators increased in the CSF of
T. b. gambienseHAT patients (Hainard et al., 2009).
In conclusion, the present findings show that sleep-wake-
regulatory OX and MCH neurons are vulnerable to the infection
caused by a human-pathogenic parasite responsible for the
vast majority of HAT cases, and indicate that MCH neurons
are especially susceptible to this infection. HAT causes a
paradigmatic chronic progressive neuroinflammation, and the
present data could therefore have pathogenetic implications for
sleep disorders in other chronic neuroinflammatory conditions.
Concerning HAT, the data recall the importance of an early
diagnosis and therapy to favor compensation and recovery of
vulnerable neuronal cell types damaged during the disease.
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